The present study investigated the proliferative activity of ameloblastoma variants, such as SMA, UA, and desmoplastic ameloblastoma, through Ki-67 immunohistochemical expression, aiming to correlate these findings with their clinical behavior, aggressiveness, and recurrence potential. Here, MKI67 is linked to ameloblastoma.